Loading...
Perspective on the Budgetary Impact of FP/FORM pMDI on Treatment and Management of Exacerbation in Moderate-to-Severe Asthma Patients in Singapore
PURPOSE: Reducing the risk of exacerbation is a long-term goal of managing moderate-to-severe asthma. The use of fluticasone propionate/formoterol fumarate dihydrate (FP/FORM) pressurized metered-dose (pMDI, Flutiform(®)), a type of inhaled corticosteroid (ICS) and long-acting β2 agonist (LABA) fixe...
Na minha lista:
| Udgivet i: | Clinicoecon Outcomes Res |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7547776/ https://ncbi.nlm.nih.gov/pubmed/33116696 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S262267 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|